Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05138874 · ClinicalTrials.gov registry record · NA
Improving Safe Antibiotic Prescribing in Telehealth
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 6,581
- Enrollment target
NCT05138874: Completed NA study, sponsored by University of Southern California.
NCT05138874 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 6,581 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (369% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05138874, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,581 participants
- Enrollment target
Study Summary
Appropriate use of antibiotics reduces resistance and protects patients from unnecessary harm. Important advances in antibiotic stewardship have been achieved in outpatient settings, but little is known about stewardship in the rapidly growing telehealth sector. Prior pragmatic randomized trials have shown that Centers for Disease Control (CDC) Core Element interventions constructed using insights from decision and social psychology can greatly reduce inappropriate prescribing in outpatient settings. In a randomized trial, the investigators will adapt and test two aspects of CDC Core Elements in a telehealth environment (Teladoc®), each with two levels of intensity. Teladoc® clinicians will be randomized to the following interventions: 1) Performance Feedback (Trending, Benchmark Peer Comparison), 2) Commitment (Private, Public), or 3) Control. All randomization occurs at the provider level, with the exception of the Public Commitment arm, which requires patient-facing content that is determined by patient state. Clinicians and members will see the same messages across all pages, all channels \& all consults during the 12-month study period. The primary outcome is to assess change in antibiotic prescribing rate for qualifying acute respiratory infection visits (ARIs).
Primary Outcome
Change in antibiotic prescribing rate for acute respiratory infection visits based on the International Statistical Classification of Diseases, version 10 (ICD-10) codes including: non-specific upper respiratory infections, otitis media, sinusitis, pharyngitis, bronchitis, influenza, and COVID-19.
Interventions
- BEHAVIORAL Trending Feedback
- BEHAVIORAL Benchmark Peer Comparison Feedback
- BEHAVIORAL Private Commitment
- BEHAVIORAL Public Commitment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,581 participants |
| Start Date | 2022-03-03 |
| Est. Completion | 2023-09-21 |
| Phase | NA |
What the finished NCT05138874 record still lists
NCT05138874 is an interventional study that assigns participants to a tested intervention. Its 6,581 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (369% higher).
The record links to 0 conditions, and to 4 interventions - of which Trending Feedback is the first listed.
NCT05138874 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05138874 about?
NCT05138874 is a clinical study titled "Improving Safe Antibiotic Prescribing in Telehealth". Appropriate use of antibiotics reduces resistance and protects patients from unnecessary harm. Important advances in antibiotic stewardship have been achieved in outpatient settings, but little is known about stewardship in the rapidly growing telehealth sector. Prior pragmatic randomized trials hav...
What is the current status of trial NCT05138874?
This trial is currently completed. It is a NA study. The enrollment target is 6,581 participants. The study started on 2022-03-03. Estimated completion is 2023-09-21.
What interventions are being tested in trial NCT05138874?
The interventions under investigation include: Trending Feedback (BEHAVIORAL), Benchmark Peer Comparison Feedback (BEHAVIORAL), Private Commitment (BEHAVIORAL), Public Commitment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05138874?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05138874's enrollment target sits among peer trials
6,581 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
- NCT05515224 · 6,600 participants · NA
5-Cog 2.0: A Pragmatic Clinical Trial
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI